SciBase Holding AB (publ)

OM:SCIB Stock Report

Market Cap: SEK 92.2m

SciBase Holding Valuation

Is SCIB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of SCIB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SCIB?

Key metric:

The above table shows the Price to Sales ratio for SCIB. This is calculated by dividing SCIB's market cap by their current revenue.
What is SCIB's PS Ratio?
PS Ratio3.4x
SalesSEK 26.87m
Market CapSEK 92.21m

Price to Sales Ratio vs Peers

How does SCIB's PS Ratio compare to its peers?

The above table shows the PS ratio for SCIB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.9x
DIGN Dignitana
1.1x20.6%SEK 96.7m
REDS Redsense Medical
4.9xn/aSEK 118.4m
EPIS B Episurf Medical
6.6x93.5%SEK 82.0m
MCLR Medclair
2.9xn/aSEK 123.7m
SCIB SciBase Holding
3.4x47.9%SEK 92.2m


Price to Sales Ratio vs Industry

How does SCIB's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
1x3.9%US$977.63m
CARE Careium
0.8x10.0%US$62.09m
ADDV A ADDvise Group
0.8x9.2%US$47.25m
BOUL Boule Diagnostics
0.7x6.2%US$33.06m
SCIB 3.4xIndustry Avg. 5.3xNo. of Companies12PS048121620+
12 CompaniesEstimated GrowthMarket Cap
No more companies


Price to Sales Ratio vs Fair Ratio

What is SCIB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SCIB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.4x
Fair PS Ratio7.2x


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Price Target
Consensus Narrative from 1 Analyst
SEK 1.60
Fair Value
73.8% undervalued intrinsic discount
1
Number of Analysts


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 05:22
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SciBase Holding AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christian LeePareto Securities
Mats HyttingeRedeye